CIMP status of interval colon cancers: Another piece to the puzzle

American Journal of Gastroenterology

Volumn 105, Issue 5, 2010, Pages 1189-1195

  Arain, Mustafa A ^a   Sawhney, Mandeep ^b   Sheikh, Shehla ^a   Anway, Ruth ^a   Thyagarajan, Bharat ^c   Bond, John H ^a   Shaukat, Aasma ^a,d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CARCINOGENESIS; COLON CANCER; COLONOSCOPY; CONTROLLED STUDY; CPG ISLAND; FEMALE; HUMAN; INTERVAL CANCER; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PHENOTYPE; PRIORITY JOURNAL;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; COLONOSCOPY; CONFIDENCE INTERVALS; CPG ISLANDS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MALE; MICROSATELLITE INSTABILITY; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; ODDS RATIO; PROBABILITY; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 77951974883     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.699     Document Type: Article

References (26)

1. Levin B, Lieberman DA, McFarland B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570-1595 (Pubitemid 351615355)
2. Kahi CJ, Rex DK, Imperiale TF. Screening, surveillance, and primary prevention for colorectal cancer: a review of the recent literature. Gastroenterology 2008; 135: 380-399
3. Barclay RL, Vicari JJ, Doughty AS et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. The New England Journal of Medicine 2006; 355: 2533-2541
4. Robertson DJ, Lieberman DA, Winawer SJ et al. Interval cancer aft er total colonoscopy: results from a pooled analysis of eight studies. Gastroenterology 2008; 134: A111-112
5. Gorski TF, Rosen L, Riether R et al. Colorectal cancer aft er surveillance colonoscopy: false-negative examination or fast growth? Diseases of the Colon and Rectum 1999; 42: 877-880
6. Jass JR. Classifi cation of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007; 50: 113-130
7. Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 2008; 135: 1079-1099
8. Ogino S, Nosho K, Kirkner GJ et al. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 2009; 58: 90-96
9. Sawhney MS, Farrar WD, Gudiseva S et al. Microsatellite instability in interval colon cancers. Gastroenterology 2006; 131: 1700-1705
10. Toyota M, Ahuja N, Ohe-Toyota M et al. CpG island methylator phenotype in colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America 1999; 96: 8681-8686
11. Samowitz WS, Albertsen H, Herrick J et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 2005; 129: 837-845
12. Goel A, Nagasaka T, Arnold CN et al. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 2007; 132: 127-138
13. Hawkins N, Norrie M, Cheong K et al. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 2002; 122: 1376-1387
14. Weisenberger DJ, Siegmund KD, Campan M et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nature Genetics 2006; 38: 787-793
15. van Rijnsoever M, Grieu F, Elsaleh H et al. Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut 2002; 51: 797-802.
16. Ferracin M, Gafa R, Miotto E et al. The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profi le. The Journal of Pathology 2008; 214: 594-602.
17. Ogino S, Meyerhardt JA, Kawasaki T et al. CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma. Virchows Arch 2007; 450: 529-537
18. Shen L, Catalano PJ, Benson AB III et al. Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fl uorouracil based chemotherapy. Clin Cancer Res 2007; 13: 6093-6098
19. Ward RL, Cheong K, Ku SL et al. Adverse prognostic eff ect of methylation in colorectal cancer is reversed by microsatellite instability. J Clin Oncol 2003; 21: 3729-3736
20. Lee S, Cho NY, Choi M et al. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation. Pathology International 2008; 58: 104-113
21. Van Rijnsoever M, Elsaleh H, Joseph D et al. CpG island methylator phenotype is an independent predictor of survival benefi t from 5-fl uorouracil in stage III colorectal cancer. Clin Cancer Res 2003; 9: 2898-2903
22. Gryfe R, Kim H, Hsieh ET et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. The New England Journal of Medicine 2000; 342: 69-77.
23. Lim SB, Jeong SY, Lee MR et al. Prognostic signifi cance of microsatellite instability in sporadic colorectal cancer. International Journal of Colorectal Disease 2004; 19: 533-537
24. Goldstein NS. Serrated pathway and APC (conventional)-type colorectal polyps: molecular-morphologic correlations, genetic pathways, and implications for classifi cation. American Journal of Clinical Pathology 2006; 125: 146-153
25. Kambara T, Simms LA, Whitehall VL et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004; 53: 1137-1144
26. Kakar S, Deng G, Cun L et al. CpG island methylation is frequently present in tubulovillous and villous adenomas and correlates with size, site, and villous component. Human Pathology 2008; 39: 30-36